Unknown

Dataset Information

0

Specificities of the DMD Gene Mutation Spectrum in Russian Patients.


ABSTRACT: Duchenne/Becker muscular dystrophy (DMD/BMD) is the most common form of muscular dystrophy, accounting for over 50% of all cases. In this regard, in Russia we carry out a program of selective screening for DMD/BMD, which mainly involves male patients. The main inclusion criteria are an increase in the level of creatine phosphokinase (>2000 U/L) or an established clinical diagnosis. At the first stage of screening, patients are scanned for extended deletions and duplications in the DMD gene using multiplex ligase-dependent probe amplification (MLPA SALSA P034 and P035 DMD probemix, MRC-Holland). The second stage is the search for small mutations using a custom NGS panel, which includes 31 genes responsible for various forms of limb-girdle muscular dystrophy. In a screening of 1025 families with a referral Duchenne/Becker diagnosis, pathogenic and likely pathogenic variants in the DMD gene were found in 788 families (in 76.9% of cases). In the current study, we analyzed the mutation spectrum of the DMD gene in Russian patients and noted certain differences between the examined cohort and the multi-ethnic cohort. The analysis of the DMD gene mutation spectrum is essential for patients with DMD/BMD because the exact mutation type determines the application of a specific therapeutic method.

SUBMITTER: Zinina E 

PROVIDER: S-EPMC9658738 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Specificities of the DMD Gene Mutation Spectrum in Russian Patients.

Zinina Elena E   Bulakh Maria M   Chukhrova Alena A   Ryzhkova Oksana O   Sparber Peter P   Shchagina Olga O   Polyakov Aleksander A   Kutsev Sergey S  

International journal of molecular sciences 20221022 21


Duchenne/Becker muscular dystrophy (DMD/BMD) is the most common form of muscular dystrophy, accounting for over 50% of all cases. In this regard, in Russia we carry out a program of selective screening for DMD/BMD, which mainly involves male patients. The main inclusion criteria are an increase in the level of creatine phosphokinase (>2000 U/L) or an established clinical diagnosis. At the first stage of screening, patients are scanned for extended deletions and duplications in the DMD gene using  ...[more]

Similar Datasets

| S-EPMC7288340 | biostudies-literature
| S-EPMC9167825 | biostudies-literature
| S-EPMC4712497 | biostudies-literature
| S-EPMC10000533 | biostudies-literature
| S-EPMC8282982 | biostudies-literature
| S-EPMC5451382 | biostudies-literature
| S-EPMC6838919 | biostudies-literature
| S-EPMC8659554 | biostudies-literature
| S-EPMC5040013 | biostudies-literature
| S-EPMC6819651 | biostudies-literature